Aarti Pharmalabs Ltd - 543748 - Record Date For Interim Dividend
Record date for Interim dividend07-02-2024
07-02-2024
Aarti Pharmalabs Ltd - 543748 - Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2023
Audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 202307-02-2024
Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Board Meeting Outcome For Financial Results And Interim Dividend
Financial results and Interim dividend07-02-2024
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Conference Call to discuss the Company''s Q3/ 9M- FY24 Results01-02-2024
Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Audited Financial Results For The Quarter And Nine Months Ended December 31, 2023, Interim Dividend, If Any, For The FY 2023-24 And Other Business Matters, If Any.
Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 ,inter alia, to consider and approve Audited Financial Results for the quarter and nine months ended December 31, 2023, Interim Dividend, if any, for the FY 2023-24 and other business matters, if any.30-01-2024
Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 202308-01-2024
Aarti Pharmalabs Ltd - 543748 - Intimation Of Grant Of Options Under APL Performance Stock Option Plan 2023
Intimation of Grant of Options under APL Performance Stock Option Plan 202304-01-2024
Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window
Intimation of closure of Trading Window28-12-2023
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Formal Inauguration of Research & Development Laboratory (R&D-III) at Nerul, Navi Mumbai18-12-2023
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Conference Call for Q2 FY24 Financial Results held on November 9, 202313-11-2023